Nevertheless, this experimental setup seems sufficient to demonstrate that the LNP-siVwf is capable to strongly silence endothelial Vwf, reducing circulating and localized VWF under conditions of hypercholesterolemia and a diseased atherothrombosis-prone vasculature. Here, VWF is linked to Hypercholesterolemia.